CRFRX
Price
$11.26
Change
-$0.04 (-0.35%)
Updated
May 22 closing price
Net Assets
N/A
RMFEX
Price
$56.37
Change
-$0.15 (-0.27%)
Updated
May 22 closing price
Net Assets
103.21B
Interact to see
Advertisement

CRFRX vs RMFEX

Header iconCRFRX vs RMFEX Comparison
Open Charts CRFRX vs RMFEXBanner chart's image
Calvert Focused Value R6
Price$11.26
Change-$0.04 (-0.35%)
VolumeN/A
Net AssetsN/A
American Funds American Mutual R4
Price$56.37
Change-$0.15 (-0.27%)
VolumeN/A
Net Assets103.21B
CRFRX vs RMFEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CRFRX vs. RMFEX commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRFRX is a Buy and RMFEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX pays higher dividends than CRFRX: RMFEX (1.65) vs CRFRX (1.34). CRFRX was incepted earlier than RMFEX: CRFRX (3 years) vs RMFEX (23 years). CRFRX (0.88) is less costly to investors than RMFEX (0.62). CRFRX is a more actively managed with annual turnover of: 107.00 vs. RMFEX (31.00). RMFEX has a lower initial minimum investment than CRFRX: RMFEX (250) vs CRFRX (5000000). RMFEX annual gain was more profitable for investors over the last year : 5.55 vs. CRFRX (-1.60).
CRFRXRMFEXCRFRX / RMFEX
Total Expense Ratio0.740.62119%
Annual Report Gross Expense Ratio0.880.62142%
Fund Existence3 years23 years-
Gain YTD-0.8773.037-29%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net AssetsN/A103B-
Annual Yield % from dividends1.341.6581%
Returns for 1 year-1.605.55-29%
Returns for 3 years18.2819.5793%
Returns for 5 yearsN/A61.67-
Returns for 10 years21.8367.9832%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYLIX95.59N/A
N/A
Rydex Leisure Inv
JLVIX68.92N/A
N/A
JHancock Fundamental Large Cap Core I
SDVRX24.20N/A
N/A
PGIM Quant Solutions Mid-Cap Val R
PGHAX60.41N/A
N/A
Putnam Global Health Care R6
MCSDX40.03-0.10
-0.25%
NYLI WMC Enduring Capital Class R6